In this study, we conducted high-throughput TCR-seq on CD8+ T cells sorted from the dLN, PBL, and tumor in a B16F10 mouse melanoma model to investigate the effects of anti-CD4 mAb treatment on the CD8+ T cell repertoire. This evidence concerns the gene CD8A and melanoma.